,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #gaac  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,june #d1 #bjbj,ms4   
,s*ak[sky introduc$ ! foll[+ bill2 :i* 0
 ref]r$ to ! ,committee on ,en]gy &     
,comm]ce  ,a ,,bill  ,to am5d ! ,public 
,heal? ,s]vice ,act to e/abli% an       
,em]g5cy ,(fice ( ,manufactur+ = ,public
 ,heal?1 & = o!r purposes4  #a4 ,%ort   
title ,?is ,act may be cit$ z !         
,,covid-#ai ,em]g5cy ,manufactur+ ,act (
 #bjbj4  #b4 ,public manufactur+ (      
ph>maceuticals ,"p ,a ( title ,,iii ( ! 
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bda et seq47 is am5d$ by add+
 at ! end ! foll[+3  #caj;,b4           
,manufactur+ ( drugs1 biological        
products1 devices1 & p]sonal protective 
equipm5t  7a7 ,em]g5cy (fice (          
manufactur+ = public heal?  7#a7        
,e/abli%m5t ,!re is e/abli%$ )9 !       
,dep>tm5t ( ,heal? & ,human ,s]vices an 
(fice to be kn[n z ! ,em]g5cy ,(fice (  
,manufactur+ = ,public ,heal? 7ref]r$ to
 9 ?is section z ! ,(fice74  7#b7       

,purpose ,! purposes ( ! ,(fice are--   
7,a7 to ensure an adequate supply (1 &  
increase access to1 prescription drugs1 
biological products1 devices1 & o!r     
supplies1 includ+ p]sonal protective    
equipm5t1 necess>y to1 z appropriate1   
diagnose1 mitigate1 prev5t1 or treat    
,,covid-#ai & to mitigate ! h>m !       
,,covid-#ai p&emic might o!rwise cause =
 ! /rategic national /ockpile "u section
 #cai;,f-#b1 ,f$]al1 ,/ate1 local1 &    
,native heal? programs1 & ! comm]cial   
m>ket2  7,b7 to address %ortages 9 !    
/rategic national /ockpile & comm]cial  
m>ket ( prescription drugs1 biological  
products1 devices1 & p]sonal protective 
equipm5t us$ to treat conditions o!r ?an
 ,,covid-#ai2 &  7,c7 to provide        
prescription drugs1 biological products1
 devices1 & p]sonal protective equipm5t 
necess>y to diagnose1 mitigate1 prev5t1 
& treat ,,covid-#ai & to mitigate ! h>m 
! ,,covid-#ai p&emic might o!rwise      
cause1 to ,f$]al1 ,/ate1 local1 &       
,native heal? programs1 at no co/1 & to 

consum]s 9 ! comm]cial m>ket & o!r      
int]national entities at co/4  7#c7     
,p]sonnel  7,a7 ,director  7i7 ,9 g5]al 
,! ,(fice %all be head$ by a ,director1 
:o %all be appo9t$ by ! ,presid5t1 n    
lat] ?an #ae days aft] ! date ( enactm5t
 ( ! ,,covid-#ai ,em]g5cy ,manufactur+  
,act ( #bjbj1 by & ) ! advice & cons5t (
 ! ,s5ate4  7ii7 ,act+ director ,!      
,assi/ant ,secret>y = ,prep>$ness &     
,response1 if 9 compliance ) subp>agraph
 7,c71 may s]ve z ,director ( ! ,(fice 9
 an act+ capacity until ! lat] ( ,s5ate 
confirmation ( a ,director or #c mon?s  
aft] date ( enactm5t ( ! ,,covid-#ai    
,em]g5cy ,manufactur+ ,act ( #bjbj4     
7iii7 ,comp5sation ,! ,director %all be 
comp5sat$ at ! rate prescrib$ = level   
,,iii ( ! ,executive ,s*$ule "u section 
#ecad ( title #e1 ,unit$ ,/ates ,code4  
7,b7 ,employees ,! ,director ( ! ,(fice1
 9 consultation ) ! ,secret>y1 may fix !
 numb] (1 & appo9t & direct1 all        
employees ( ! ,(fice4  7,c7 ,bann$      
individuals  7i7 ,drug company lobbyi/s 

,no =m] regi/]$ drug manufactur]        
lobbyi/-- 7,i7 may be appo9t$ to !      
position ( ,director ( ! ,(fice2 or     
7,,ii7 may be employ$ by ! ,(fice dur+ !
 #f-ye> p]iod beg9n+ on ! date on :i* ! 
regi/]$ lobbyi/ t]m9ates its regi/ration
 9 accordance ) section #d7;d7 ( !      
,lobby+ ,disclosure ,act ( #aiie or !   
ag5t t]m9ates its /atus1 z applicable4  
7ii7 ,s5ior executives ( law-break+     
companies ,no =m] s5ior executive ( a   
cov]$ entity-- 7,i7 may be appo9t$ to ! 
position ( ,director ( ! ,(fice2 or     
7,,ii7 may be employ$ by ! ,(fice dur+ !
 #f-ye> p]iod beg9n+ on ! lat] (-- 7aa7 
! date ( ! settlem5t2 &  7bb7 ! date on 
:i* ! en=cem5t action has conclud$4     
7iii7 ,cov]$ entity ,= purposes ( clause
 7ii71 ! t]m cov]$ entity means any     
entity t is-- 7,i7 a drug manufactur]2 &
  7,,ii7 7aa7 op]at+ "u ,f$]al          
settlem5t1 includ+ a ,f$]al cons5t      
decree2 or  7bb7 ! subject ( an en=cem5t
 action 9 a c\rt ( ! ,unit$ ,/ates or by
 an ag5cy4  7#d7 ,duties  7,a7 ,9 g5]al 

,! ,(fice %all-- 7i7 prep>e & submit    
applications = approval to ! ,food &    
,drug ,adm9i/ration1 or ent] into       
contracts = su* submission1 = !         
manufacture ( applicable ,,covid-#ai    
products & o!r applicable drugs1        
biological products1 & devices :5       
au?oriz$ "u ?is section2  7ii7 obta9    
rights to manufacture applicable        
,,covid-#ai products & applicable drugs1
 biological products1 & devices z       
au?oriz$ "u ?is section2  7iii7         
manufacture1 or ent] into contracts )   
entities to manufacture1 applicable     
,,covid-#ai products & o!r applicable   
drugs1 biological products1 & devices z 
au?oriz$ "u ?is section2  7iv7 det]m9e a
 fair price = ea* applicable drug1      
biological product1 & device1 9         
accordance ) subp>agraph 7,b77ii72  7v7 
sell manufactur$ applicable drugs1      
biological products1 & devices at a fair
 price1 z au?oriz$ "u ?is section2  7vi7
 provide1 at no co/1 applicable         
,,covid-#ai products to ,f$]al1 ,/ate1  

local1 & ,native heal? programs1 & o!r  
dome/ic heal? c>e provid]s & suppli]s1 z
 det]m9$ by ! ,secret>y2  7vii7 sell1   
at-co/1 applicable ,,covid-#ai products 
to o!r comm]cial entities & int]national
 entities1 9 accordance ) subp>agraph   
7,b77i72 &  7viii7 manufacture1 or ent] 
into contracts ) entities to            
manufacture1 active ph>maceutical       
+r$i5ts = use by ! ,(fice or = sale to  
o!r entities4  7,b7 ,pric+ det]m9ations 
7i7 ,at-co/ price ,9 det]m9+ an at-co/  
price = an applicable ,,covid-#ai       
product "u subp>agraph 7,a77vii7 !      
,(fice %all consid]-- 7,i7 ! co/ to !   
,f$]al ,gov]nm5t ( manufactur+ !        
applicable ,,covid-#ai product2  7,,ii7 
! adm9i/rative co/s ( op]at+ ! ,(fice2 &
  7,,iii7 ! co/ to acquire or           
manufacture applicable ,,covid-#ai      
product "u ?is section4  7ii7 ,fair     
price ,9 det]m9+ a fair price = an      
applicable drug1 biological product1 or 
device "u subp>agraph 7,a77iv7 ! ,(fice 
%all consid]-- 7,i7 ! impact ( price on 

pati5t access to ! applicable drug1     
biological product1 or device2  7,,ii7 !
 co/ ( ! applicable drug1 biological    
product1 or device to ,f$]al or ,/ate   
heal? c>e programs2  7,,iii7 ! co/ to ! 
,f$]al ,gov]nm5t ( manufactur+ !        
applicable drug1 biological product1 or 
device2  7,,iv7 ! adm9i/rative co/s (   
op]at+ ! ,(fice2  7,v7 ! co/ to acquire 
or manufacture ! applicable drug1       
biological product1 or device "u ?is    
section2 &  7,,vi7 ! impact ( price on  
m>ket competition = ! applicable drug1  
biological product1 or device4  7iii7   
,transp>5cy ,all prices *>g$ =          
applicable ,,covid-#ai products &       
applicable drugs1 biological products1  
or devices %all be made publicly        
available by ! ,(fice4  7,c7 ,obta9+    
rights to manufacture & m>ket  7i7 ,9   
g5]al ,:5 necess>y to fulfill ! ,(fice's
 duties "u ?is section1 ! ,(fice %all   
acquire ! rights to manufacture & m>ket 
applicable ,,covid-#ai products &       
applicable drugs1 biological products1 &

 devices z au?oriz$ "u ?is section4     
7ii7 ,lic5s+ au?ority  7,i7 ,9 g5]al    
,not)/&+ any o!r provision ( law1 !     
,secret>y %all issue lic5ses1 z useful =
 fulfill+ ! duties "u ?is ,act1 all[+ ! 
,(fice to practice or h practic$ 7:i*   
may include lic5sure ( retroactive      
practice7 any inv5tion 9 ! ,unit$ ,/ates
 or t]ritories ( ! ,unit$ ,/ates1       
includ+ mak+1 us+1 (f]+ to sell or      
sell+1 import+1 or export+ su* inv5tion1
 to ref]5ce or rely ^u cl9ical trial    
data submitt$ to a regulatory au?ority  
or ! grant ( m>ket+ approval1 & to      
access & use o!rwise confid5tial        
in=mation1 includ+ "k-h[1 relat$ to !   
manufacture ( an applicable ,,covid-#ai 
product or applicable drug1 biological  
product1 or device4  7,,ii7             
,non-volunt>y lic5s+ ,= any lic5se t    
involves a non-volunt>y au?orization to 
use pat5t$ inv5tions1 regulatory te/    
data1 data1 "k-h[ or o!r intellectual   
prop]ty rights1 ! lic5se %all provide = 
reasonable remun]ation to rights hold]s 

su* z a reasonable royalty on ! sales ( 
product1 a #a-"t paym5t1 or "s          
comb9ation1 provid$ t ! comb9$ royalty  
paym5ts to all rights hold]s %all n     
exce$ ! p]c5tage ( sales t is ! av]age  
p]c5t ( all royalty paym5ts report$ to !
 ,int]nal ,rev5ue ,s]vice by companies 9
 ! ph>maceutical & m$ic9es sector1 ,nor?
 ,am]ican ,indu/ry ,classification      
,sy/em code #cbedaj1 provid$ t :5       
products are di/ribut$ = free1 ! royalty
 %all be bas$ ^u ! co/ ( goods4 ,:5 !re 
are multiple rights hold]s1 ! allocation
 ( ! total royalty paym5ts %all be      
det]m9$ by-- 7aa7 agreem5t among !      
rights hold]s2  7bb7 allocation by      
arbitration among ! rights hold]s2 or   
7cc7 if nei!r item 7aa7 nor 7bb7        
applies1 by ! ,(fice4  7iii7 ,transp>5cy
 ,subject to clause 7iv71 ! ,secret>y   
%all po/ any contract agreem5t "u       
subp>agraph 7,a7 or lic5se issu$ "u     
clause 7ii7 on ! public int]net website 
( ! ,dep>tm5t ( ,heal? & ,human         
,s]vices1 on ! date on :i* su* agreem5t 

or lic5se takes effect4  7iv7 ,protect$ 
in=mation ,9 c>ry+ out ?is section1 !   
,secret>y %all en=ce applicable law     
conc]n+ ! protection ( confid5tial      
comm]cial in=mation & trade secrets4    
7,d7 ,active ph>maceutical +r$i5ts  7i7 
,9 g5]al ,! ,(fice %all manufacture1 or 
ent] into contracts ) entities to       
manufacture1 an active ph>maceutical    
+r$i5t applicable to a drug or          
biological product t is ei!r an         
applicable ,,covid-#ai product or an    
applicable drug or biological product   
if-- 7,i7 ! ,(fice det]m9es t su* +r$i5t
 is n readily available f exi/+ suppli]s
 or ! exi/+ supply ( su* +r$i5t to !    
dome/ic m>ket is vuln]able to           
disruption2  7,,ii7 ! manufacture ( su* 
+r$i5t w\ld improve ! ability ( o!r     
entities to ent] ! m>ket = ! manufacture
 ( applicable ,,covid-#ai products or   
applicable drugs1 biological products1  
or devices1 or o!rwise exp& !           
manufacture ( applicable ,,covid-#ai    
products or applicable drugs1 biological

 products1 or devices2 or  7,,iii7 !    
manufacture ( su* +r$i5t is necess>y = !
 ,(fice to c>ry out its duties "u ?is   
section4  7ii7 ,price det]m9ations ,9   
det]m9+ ! price at :i* to sell an active
 ph>maceutical +r$i5t manufactur$ 9     
accordance ) clause 7i71 ! ,(fice %all  
consid] ! co/ to manufacture ! +r$i5t1 !
 adm9i/rative co/s ( ! ,(fice ) respect 
to ! +r$i5t1 & ! impact ( su* price on  
m>ket competition = ! +r$i5t4  7,e7     
,priority ,9 aw>d+ contracts "u ?is     
p>agraph1 ! ,(fice %all prioritize      
entities manufactur+ applicable         
,,covid-#ai products & applicable drugs1
 biological products1 & devices us+     
compon5ts orig9at+ & manufactur$ 9 !    
,unit$ ,/ates4  7,f7 ,contract          
requirem5ts ,all contracts issu$ "u ?is 
p>agraph %all include a requirem5t t !  
contract recipi5ts reasonably price     
products produc$ "u ! contract4  7b7    
,manufactur+ ( products  7#a7 ,9 g5]al  
,z soon z practicable aft] ! date (     
enactm5t ( ?is section1 b no lat] ?an #a

 mon? aft] su* date ( enactm5t1 ! ,(fice
 %all beg9-- 7,a7 manufactur+1 or ent]+ 
into contracts ) entities = !           
manufacture ( applicable ,,covid-#ai    
products & applicable drugs1 biological 
products1 & devices1 prioritiz+ drugs1  
biological products1 devices or p]sonal 
protective equipm5t ! manufacture ( :i* 
w\ld provide ! greate/ public heal?     
impact2 &  7,b7 con/ruct+1 or ent]+ into
 contracts to con/ruct1 manufactur+     
facilities1 includ+ ! con/ruction (     
advanc$ manufactur+ te*nology1 ,,rna    
vacc9es1 ,,dna vacc9es1 recomb9ant      
prote9 vacc9es1 viral vector-bas$       
vacc9es1 live att5uat$ vacc9es1         
inactivat$ vacc9es1 or o!r !rapeutics1  
aft] cl9ical data relat+ to su* products
 h demon/rat$ /rong positive indications
 ( safety & efficacy1 to ensure imm$iate
 production at-scale ^u ,f$]al approval4
  7#b7 ,submission ( applications ,= ea*
 applicable ,,covid-#ai product1 & = ea*
 applicable drug1 biological product1 or
 device t ! ,(fice det]m9es %\ld be     

manufactur$1 z provid$ = "u ?is section1
 ! ,secret>y %all-- 7,a7 submit an      
application "u subsection 7b7 or 7j7 (  
section #eje1 or "u section #eae1 ( !   
,f$]al ,food1 ,drug1 & ,cosmetic ,act or
 subsection 7a7 or 7k7 ( section #cea ( 
?is ,act or submit a notification "u    
section #eaj7k7 ( ! ,f$]al ,food1 ,drug1
 & ,cosmetic ,act 7or ent] into a       
contract ) ano!r entity to submit su* an
 application or notification72  7,b7    
reque/ an em]g5cy use au?orization ( !  
product "u section #efd;,a ( ! ,f$]al   
,food1 ,drug1 & ,cosmetic ,act 7or ent] 
into a contract ) ano!r entity to submit
 an application = su* use72 or  7,c7    
obta9 f ! hold] ( an application approv$
 "u subsection 7c7 or 7j7 ( section #eje
 or section #eae ( ! ,f$]al ,food1      
,drug1 & ,cosmetic ,act or subsection   
7a7 or 7k7 ( section #cea ( ! ,public   
,heal? ,s]vice ,act1 or cle>$ "u section
 #eaj7k7 ( ! ,f$]al ,food1 ,drug1 &     
,cosmetic ,act1 rights to manufacture   
su* applicable drug4  7#c7 ,manufactur+ 

timel9es  7,a7 ,p]sonal protective      
equipm5t ,n lat] ?an #a mon? aft] ! date
 ( enactm5t ( ?is section1 ! ,secret>y  
%all beg9 ! public manufactur+ ( p]sonal
 protective equipm5t1 includ+ surgical  
masks1 surgical g[ns1 face %ields1 &    
,n#ie masks1 meet+ ! def9ition (        
applicable ,,covid-#ai product & 9      
accordance ) ?is section4  7,b7         
,,covid-#ai diagno/ic te/ mat]ials ,n   
lat] ?an #a mon? aft] ! date ( enactm5t 
( ?is section1 ! ,secret>y %all beg9 !  
public manufactur+ ( mat]ials necess>y =
 ! developm5t ( ,,covid-#ai diagno/ic   
te/s1 includ+ *emical reag5ts1 te/      
swabs1 & mat]ials necess>y to develop   
s]ological ,,covid-#ai te/s1 meet+ !    
def9ition ( applicable ,,covid-#ai      
product & 9 accordance ) ?is section4   
7,c7 ,,covid-#ai treatm5t drugs ,z soon 
z practicable aft] ! date ( enactm5t (  
?is section1 ! ,secret>y %all beg9 !    
public manufactur+ ( drugs & biological 
products 9 %ortage1 & any devices us$ to
 adm9i/] su* drugs & biological         

products1 t are us$ = treatm5t ( sev]e  
,,covid-#ai cases1 includ+ albut]ol1    
drugs us$ to intubate pati5ts1          
antibiotics1 & antivirals1 meet+ !      
def9ition ( applicable ,,covid-#ai      
product & 9 accordance ) ?is section4   
7#d7 ,priority manufactur+ ,! ,(fice    
%all prioritize ! manufactur+ (         
applicable ,,covid-#ai products &       
applicable drugs1 biological products1 &
 devices t w\ld h ! greate/ impact on-- 
7,a7 diagnos+1 mitigat+1 prev5t+1       
treat+1 or cur+ ,,covid-#ai2  7,b7      
limit+ ! h>m ! ,,covid-#ai p&emic might 
o!rwise cause to public heal? & !       
economy2  7,c7 address+ %ortages (      
drugs1 biological1 products1 & devices2 
7,d7 r$uc+ ! co/ ( combat+ ,,covid-#ai  
to ,f$]al1 ,/ate1 local1 & ,native heal?
 programs2 &  7,e7 alleviat+ demographic
 disp>ities 9 ,,covid-#ai outcomes or   
access to diagnosis1 mitigation1        
prev5tion1 & treatm5t4  7c7 ,provision (
 products  7#a7 ,provision ( applicable 
,,covid-#ai products ,! ,secret>y %all  

provide applicable ,,covid-#ai products 
at no co/ to ,f$]al1 ,/ate1 local1 &    
,native heal? programs1 & o!r dome/ic   
heal? c>e provid]s & suppli]s1 includ+  
dome/ic comm]cial heal? c>e provid]s1 z 
det]m9$ by ! ,secret>y1 & sell at co/   
applicable ,,covid-#ai products to o!r  
comm]cial entities & int]national       
entities4 ,am\nts receiv$ f ! sale ( su*
 drugs %all be us$ = ! activities ( !   
,(fice4  7#b7 ,provision ( applicable   
drugs1 biological products & devices ,! 
,secret>y %all sell applicable drugs1   
biological products1 & devices produc$  
"u ?is section at a fair price to o!r   
entities4 ,am\nts receiv$ f ! sale ( su*
 drugs %all be us$ to repl5i% ! national
 /rategic /ockpile "u section           
#cai;,f-#b4  7d7 ,ov]sight ( contracts  
,9 ! case ( applicable ,,covid-#ai      
products & applicable drugs1 biological 
products1 & devices manufactur$ via     
contracts1 ! ,inspector ,g5]al ( !      
,dep>tm5t ( ,heal? & ,human ,s]vices    
%all conduct a review ( n few] ?an #a ( 

e #c contracts ent]$ into "u ?is        
section1 & ( ! entities ent]+ into su*  
contracts1 to ensure t ! ,(fice is issu+
 contracts "u fair & reasonable t]ms &  
conditions1 includ+ facilitat+ !        
procurem5t by ! ,f$]al ,gov]nm5t (      
applicable ,,covid-#ai products &       
applicable drugs1 biological products1 &
 m$ical devices at fair & reasonable    
prices4 ,! ,inspector ,g5]al %all make  
ea* su* review public &1 9 cases :]e su*
 a review id5tifies unreasonable prices1
 submit recomm5dations to ,congress on  
h[ ! ,(fice %\ld improve its contract+  
sy/ems to ensure reasonable pric+4  7e7 
,reports to ,congress ,! ,director %all 
prep>e & submit to ! ,presid5t1 !       
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions ( ! ,s5ate1 & !      
,committee on ,en]gy & ,comm]ce ( !     
,h\se ( ,repres5tatives1 a mon?ly report
 dur+ ! public heal? em]g5cy decl>$ by !
 ,secret>y "u section #cai on ,janu>y   
#ca1 #bjbj1 ) respect to ,,covid-#ai1 & 
a f9al report #c mon?s aft] ! public    

heal? em]g5cy has conclud$1 t includes--
 7#a7 an assessm5t ( ! major supply *a9 
*all5ges fac+ hospitals1 m$ical         
provid]s1 ! ,f$]al ,gov]nm5t1 ,/ate1    
local1 & tribal gov]nm5ts1 & ! private  
sector 9 procur+ drugs1 biological      
products1 devices1 & p]sonal protective 
equipm5t to combat & prev5t ! spread (  
,,covid-#ai2 &  7#b7 a description ( !  
/atus ( all drugs1 biological products1 
devices1 active ph>maceutical +r$i5ts1 &
 p]sonal protective equipm5t = :i*      
manufactur+ has be5 au?oriz$ "u ?is     
section1 includ+ drugs1 biological      
products1 devices1 active ph>maceutical 
+r$i5ts1 & p]sonal protective equipm5t  
be+ manufactur$1 drugs1 biological      
products1 devices1 active ph>maceutical 
+r$i5ts1 & p]sonal protective equipm5t =
 :i* ! ,(fice has submitt$ an           
application = approval or a notification
 = cle>ance or classification to ! ,food
 & ,drug ,adm9i/ration b has n yet      
receiv$ approval1 cle>ance1 or          
classification1 & drugs1 biological     

products1 devices1 active ph>maceutical 
+r$i5ts1 & p]sonal protective equipm5t =
 :i* ! ,(fice has receiv$ approval1     
cle>ance1 or classification f ! ,food & 
,drug ,adm9i/ration b are n be+         
manufactur$4  7f7 ,def9itions ,9 ?is    
section3 7#a7 ,applicable drug1         
biological product1 or device def9ition 
,! t]m applicable drug1 biological      
product1 or device means a drug 7z def9$
 9 section #bja7;g7 ( ! ,f$]al ,food1   
,drug1 & ,cosmetic ,act71 biological    
product 7z def9$ 9 section #cea7;i7 ( ! 
,public ,heal? ,s]vice ,act71 comb9ation
 product 7z describ$ 9 section #ejc7;g7 
( ! ,f$]al ,food1 ,drug1 & ,cosmetic    
,act71 or device 7z def9$ 9 section     
#bja7;h7 ( ! ,f$]al ,food ,drug &       
,cosmetic ,act7 = :i* an approv$        
application "u section #eje or #eae ( ! 
,f$]al ,food1 ,drug1 & ,cosmetic ,act or
 section #cea ( ! ,public ,heal? ,s]vice
 ,act1 or cle>ance "u section #eaj7k7 ( 
! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1
 is 9 effect1 &-- 7,a7 is includ$ 9 !   

drug %ortage li/ "u section #ejf;,e ( ! 
,f$]al ,food1 ,drug1 & ,cosmetic ,act2  
or  7,b7 is vuln]able to %ortage4  7#b7 
,applicable ,,covid-#ai product         
def9ition  7,a7 ,9 g5]al ,! t]m         
applicable ,,covid-#ai product means a  
product t is includ$ on a li/ t !       
,secret>y ( ,heal? & ,human ,s]vices1 9 
consultation ) ! ,commission] ( ,food & 
,drugs1 ! ,assi/ant ,secret>y =         
,prep>$ness & ,response1 & ! ,director (
 ! ,c5t]s = ,disease ,control &         
,prev5tion1 %all compile n lat] ?an #b  
weeks aft] ! date ( enactm5t ( ?is      
section & %all review & update1 z       
necess>y1 e #b weeks ( -- 7i7 qualifi$  
p&emic or epidemic products1 z def9$ "u 
section #cai;,f-#c1 t are-- 7,i7 7aa7   
drugs1 biological products1 & devices t 
are manufactur$1 us$1 design$1 develop$1
 modifi$1 lic5s$ or procur$-- 7,,aa7 to 
diagnose1 mitigate1 prev5t1 treat1 or   
cure ,,covid-#ai2 or 7,,bb7 to limit !  
h>m ! ,,covid-#ai p&emic might o!rwise  
cause2  7bb7 drugs1 biological products1

 & devices t are manufactur$1 us$1      
design$1 develop$1 modifi$1 lic5s$1 or  
procur$ to diagnose1 mitigate1 prev5t1  
treat1 or cure a s]i\s or life-?reat5+  
disease or condition caus$ by a product 
describ$ 9 item 7aa72 or  7cc7 drugs1   
biological products1 devices or         
te*nologies int5d$ to enhance ! use or  
effect ( a drug1 biological product1 or 
device describ$ 9 item 7aa7 or 7bb72 &  
7ii7 p]sonal protective equipm5t1       
includ+ protective equipm5t = eyes1     
face1 head1 & extremities1 protective   
clo?+1 respiratory devices1 & protective
 %ields & b>ri]s1 us$ to protect p f    
,,covid-#ai infection4  7,b7            
,consultation ,9 develop+ ! li/ describ$
 9 subp>agraph 7,a71 ! ,secret>y %all   
consult ) ! ,adm9i/rator ( ! ,f$]al     
,em]g5cy ,managem5t ,adm9i/ration & !   
,secret>y ( ,def5se to ensure t1 9      
in/ances :]e ! ,presid5t has enact$ !   
,def5se ,production ,act to produce     
applicable ,,covid-#ai products1 !      
,(fice does n replicate or ov]produce   

products be+ develop$ "u ! ,act4  7#c7  
,native heal? program ,! t]m ,native    
heal? program %all include-- 7,a7 a     
program provid$ ?r\gh ! ,indian ,heal?  
,s]vice2  7,b7 any heal? program op]at$ 
by-- 7i7 an ,indian tribe1 or ,tribal   
organization1 z su* t]ms are def9$ 9    
section #d ( ! ,indian                  
,self-,det]m9ation & ,education         
,assi/ance ,act2  7ii7 an int]-tribal   
consortium1 z def9$ 9 section #eja7;a7 (
 ! ,indian ,self-,det]m9ation &         
,education ,assi/ance ,act2 or  7iii7 an
 urban ,indian organization1 z def9$ 9  
section #d ( ! ,indian ,heal? ,c>e      
,improvem5t ,act2 &  7,c7 any heal?     
program provid$ ?r\gh a ,native         
,hawaiian heal? c>e sy/em1 z def9$ 9    
section #ab ( ! ,native ,hawaiian ,heal?
 ,c>e ,improvem5t ,act4  7#d7 ,dome/ic  
heal? c>e provid] ,! t]m dome/ic heal?  
c>e provid] %all include ! direct       
support pr(essional1 home heal?1 &      
p]sonal c>e att5dant work=ce4  7g7      
,au?orization ( appropriations ,!re are 

au?oriz$ to be appropriat$ su* sums z   
may be necess>y to c>ry out ?is section4
  4